Ionis Pharmaceuticals, Inc. at Wells Fargo Healthcare Conference Transcript
Okay. Thanks, everyone, for being here. My name is Yanan Zhu. I'm one of the biotech analysts here at Wells Fargo. It is my great pleasure to be joined by Brett Monia, CEO of Ionis Pharmaceuticals.
Thank you, Brett, for being here.
Thank you, Yanan, and good morning, everybody. It's great to be here.
I was wondering if you can start us off with the overview of the company, and then we can jump into questions.
Sure. Happy to. I'll be brief, though, because I know you have a lot of questions, Yanan, and we want to get to those. But as expected, this has been a highly eventful year for Ionis. We've had several really important positive strategic outcomes this year.
And we've also had some disappointments, not
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
